Exact Sciences Corp. Reports Board and Executive Compensation Changes

Ticker: EXAS · Form: 8-K · Filed: 2025-04-29T00:00:00.000Z

Sentiment: neutral

Topics: governance, executive-compensation, board-changes

TL;DR

Exact Sciences board shakeup and exec pay changes filed today.

AI Summary

Exact Sciences Corp. announced on April 29, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and the election of new directors, alongside updates to compensatory plans for key executives.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: low — This filing primarily concerns routine corporate governance and executive compensation matters, with no immediate financial implications disclosed.

Key Players & Entities

FAQ

What specific roles have seen departures of officers?

The filing indicates the departure of certain officers but does not specify the exact roles in this summary section.

When was the report filed?

The report was filed on April 29, 2025.

What is the principal business address of Exact Sciences Corp.?

The principal executive offices are located at 5505 Endeavor Lane, Madison, WI 53719.

What is the SIC code for Exact Sciences Corp.?

The Standard Industrial Classification (SIC) code is 8071, which corresponds to Medical Laboratories.

Are there any details on the new compensatory arrangements?

The filing mentions compensatory arrangements of certain officers but does not provide specific details within the provided text.

From the Filing

0001124140-25-000032.txt : 20250429 0001124140-25-000032.hdr.sgml : 20250429 20250429160157 ACCESSION NUMBER: 0001124140-25-000032 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250429 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20250429 DATE AS OF CHANGE: 20250429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EXACT SCIENCES CORP CENTRAL INDEX KEY: 0001124140 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 204782291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35092 FILM NUMBER: 25886991 BUSINESS ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 BUSINESS PHONE: 608-284-5700 MAIL ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 FORMER COMPANY: FORMER CONFORMED NAME: EXACT CORP DATE OF NAME CHANGE: 20000919 8-K 1 exas-20250429.htm 8-K exas-20250429 0001124140 false 0001124140 2025-04-29 2025-04-29 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM  8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported):  April 29, 2025   EXACT SCIENCES CORPORATION (Exact Name of Registrant as Specified in Charter)   Delaware   001-35092   02-0478229 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   5505 Endeavor Lane Madison , WI   53719 (Address of Principal Executive Offices)(Zip Code)   Registrant’s telephone number, including area code:   ( 608 ) 284-5700   Not Applicable (Former Name or Former Address, if Changed Since Last Report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐              Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐             Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value per share EXAS The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02.                       Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April 29,

View on Read The Filing